Does FOLFIRINOX have an immune modulatory effect on resectable pancreatic cancer?
B
Bert O'Neil, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Not Recruiting
100 years and younger
All
Phase
N/A
1 Location
Overview
The purpose of this study is to determine if combination chemotherapy with FOLFIRINOX modulates the immune response inf localized pancreatic cancer.
Description
The purpose of this study is to determine if combination chemotherapy with FOLFIRINOX modulates the immune response inf localized pancreatic cancer.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
pancreatic cancer
-
Age: - 100 Years
-
Gender: All
Updated on
10 May 2024.
Study ID: 1705457995